NutriStack
Alpha-Lipoic Acid and Sitagliptin, a caution.
Alpha-lipoic acid improves insulin sensitivity and sitagliptin (a DPP-4 inhibitor) prolongs endogenous GLP-1 activity. On sitagliptin alone the hypoglycemia risk is low, but additive effects matter when ALA is added on top of insulin or a sulfonylurea. ALA has also rarely triggered insulin autoimmune syndrome (Hirata syndrome) with severe spontaneous hypoglycemia.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Alpha-Lipoic Acid and Sitagliptin
- Pair type
- Caution
- Evidence (highest tier)
- Emerging
- Source citations
- 2 sources
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Emerging evidence
Caution
What is happening. Alpha-lipoic acid improves insulin sensitivity and sitagliptin (a DPP-4 inhibitor) prolongs endogenous GLP-1 activity. On sitagliptin alone the hypoglycemia risk is low, but additive effects matter when ALA is added on top of insulin or a sulfonylurea. ALA has also rarely triggered insulin autoimmune syndrome (Hirata syndrome) with severe spontaneous hypoglycemia.
Mechanism. Sitagliptin inhibits DPP-4, prolonging GLP-1 and GIP activity and augmenting glucose-dependent insulin secretion. ALA enhances insulin-stimulated GLUT4 translocation and AMPK activity. Mechanisms are independent and additive.
Recommendation. If sitagliptin is your only diabetes medication, ALA can be added with home glucose monitoring for the first 2-4 weeks. If you also take insulin or a sulfonylurea, ask your prescriber whether the other agent needs a dose reduction first.
Sources (2)
- Akbari M, Ostadmohammadi V, Lankarani KB, et al. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Metabolism. 2018;87:56-69. PMID 29990473
- Izzo V, Greco C, Corradini D, et al. Insulin autoimmune syndrome in an Argentine woman taking alpha-lipoic acid: A case report and review of the literature. SAGE Open Med Case Rep. 2018;6:2050313X18819601. PMID 30627435
Stack Score
How this pair moves the number.
Effect on the composite score
If both Alpha-Lipoic Acid and Sitagliptin are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.